Legal Representation
Attorney
Nicole Gage
USPTO Deadlines
Application History
12 events| Date | Code | Type | Description |
|---|---|---|---|
| May 20, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| May 20, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 14, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 16, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Apr 16, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Apr 16, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Apr 16, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Apr 16, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Apr 14, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 10, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 10, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Oct 16, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Small molecule chemical structures, namely, reagents for adhering radioactive agents to pharmaceutical compounds for chelating radioisotopes for scientific purposes; chemical agents for chelating radioisotopes.
First Use Anywhere:
Jul 7, 2022
First Use in Commerce:
Jul 17, 2022
Class 005
Radio-pharmaceutical preparations for the diagnosis and treatment of cancers; radio-pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of cancers; pharmaceutical agents that deliver a range of radioisotopes for therapeutic or diagnostic use.
First Use Anywhere:
May 31, 2023
First Use in Commerce:
May 31, 2023
Additional Information
Design Mark
The mark consists of the word "ratio" above the word "therapeutics" with a spiral originating above the "t" in "ratio" and curling to the right of the words with a grid pattern under the spiral.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"therapeutics"